STAM-binding protein mRNA 3′-untranslated region (STAMBP mRNA 3′-UTR) (STAMBP mRNA 3′-UTR)

The STAM-binding protein (STAMBP) mRNA 3′-untranslated region (3′-UTR) is a critical regulatory segment of the transcript encoding the STAMBP enzyme, also known as AMSH. This region contains specific sequences that serve as binding sites for microRNAs and RNA-binding proteins, which collectively determine the stability and translation rate of the STAMBP mRNA (McDonell et al., 2013, Nature Genetics). STAMBP itself is a deubiquitinating enzyme that plays a vital role in the endosomal sorting complex required for transport (ESCRT) pathway, facilitating the recycling or degradation of cell surface receptors like EGFR (Sirois et al., 2011, Journal of Biological Chemistry). Mutations or regulatory defects involving the STAMBP mRNA 3′-UTR are linked to Microcephaly-capillary malformation (MIC-CAP) syndrome, a condition characterized by severe brain and vascular abnormalities (Failla et al., 2014, American Journal of Medical Genetics). In the context of oncology, the 3′-UTR is often targeted by microRNAs like miR-181a, which can suppress STAMBP expression to inhibit tumor cell proliferation and invasion (Zhang et al., 2017, Scientific Reports). Therapeutic strategies focusing on this target involve the development of antisense oligonucleotides (ASOs) or microRNA-based drugs to modulate STAMBP levels for treating cancer or neurodevelopmental disorders. By specifically targeting the 3′-UTR, researchers can achieve post-transcriptional control over the ubiquitin-mediated protein degradation pathways that are frequently dysregulated in disease.

Other names

AMSH mRNA 3′-UTRSTAM-binding protein 3′-untranslated region3′-UTR of STAMBPAssociated Molecule with the SH3 domain of STAM mRNA 3′-UTR

Sequence-specific binding to the 3′-UTR to induce mRNA degradation or translational repression of the STAMBP transcript.